| Daniel J. Moore
|
| President, Chief Executive Officer, Director
|
|
|
Bio & Compensation
- Reuters
|
| Gregory H. Browne
|
| Chief Financial Officer, Senior Vice President - Finance
|
|
|
Age: 59
Bio & Compensation
- Reuters
|
| David S. Wise
|
| Senior Vice President, Chief Administrative Officer, Secretary
|
|
|
Age: 57
Bio & Compensation
- Reuters
|
| Milton Mayo Morris Ph.D.
|
| Senior Vice President - Research & Development
|
|
|
Age: 42
Bio & Compensation
- Reuters
|
| Darren W. Alch
|
| Chief Compliance Officer, Vice President, General Counsel, Assistant Secretary
|
|
|
Age: 46
Bio & Compensation
- Reuters
|
| Randal L. Simpson
|
| Vice President - Operations
|
|
|
Age: 52
Bio & Compensation
- Reuters
|
| Mark S. Verratti
|
| Vice President - Global Sales
|
|
|
Age: 44
Bio & Compensation
- Reuters
|
| Bruce H. KenKnight PhD
|
| Vice President - Emerging Therapies
|
|
|
Bio & Compensation
- Reuters
|
| Bryan D. Olin Ph.D.
|
| Vice President - Clinical , Quality & Regulatory Affairs
|
|
|
Age: 45
Bio & Compensation
- Reuters
|
| Hugh M. Morrison
|
| Non-Executive Independent Chairman of the Board
|
|
|
Age: 65
Bio & Compensation
- Reuters
|